CD274 and Miyoshi myopathy: During the clinical course of MM, PD-L1 expression on monocyte, myeloid and plasmacytoid DCs was increased during treatment without daratumumab, although daratumumab treatment prevented PD-L1 upregulation in patients with MM [73].